Value of prior imaging review before ordering renal sonography in the evaluation of abnormal renal function

2017 ◽  
Vol 45 (9) ◽  
pp. 537-541 ◽  
Author(s):  
Timothy J. Niesen ◽  
Nathan Finch ◽  
Mandip Gakhal ◽  
Robert M. Dressler ◽  
Howard M. Levy
Keyword(s):  
Renal Function ◽  
Renal Sonography ◽  
Abnormal Renal Function

scholarly journals Levosimendan use in patients with acute heart failure and reduced ejection fraction with or without severe renal dysfunction in critical cardiac care units: a multi-institution database study

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Cze-Ci Chan ◽  
Kuang-Tso Lee ◽  
Wan-Jing Ho ◽  
Yi-Hsin Chan ◽  
Pao-Hsien Chu
Keyword(s):  
Heart Failure ◽  
Renal Function ◽  
Ejection Fraction ◽  
Acute Heart Failure ◽  
Cardiac Care ◽  
Chang Gung Memorial Hospital ◽  
Research Database ◽  
Cohort Entry ◽  
Reduced Ejection Fraction ◽  
Abnormal Renal Function

Abstract Background Acute heart failure is a life-threatening clinical condition. Levosimendan is an effective inotropic agent used to maintain cardiac output, but its usage is limited by the lack of evidence in patients with severely abnormal renal function. Therefore, we analyzed data of patients with acute heart failure with and without abnormal renal function to examine the effects of levosimendan. Methods We performed this retrospective cohort study using data from the Chang Gung Research Database (CGRD) of Chang Gung Memorial Hospital (CGMH). Patients admitted for heart failure with LVEF ≤ 40% between January 2013 and December 2018 who received levosimendan or dobutamine in the critical cardiac care units (CCU) were identified. Patients with extracorporeal membrane oxygenation (ECMO) were excluded. Outcomes of interest were mortality at 30, 90, and 180 days after the cohort entry date. Results There were no significant differences in mortality rate at 30, 90, and 180 days after the cohort entry date between the levosimendan and dobutamine groups, or between subgroups of patients with an estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m2 and eGFR < 30 mL/min/1.73 m2 or on dialysis. The results were consistent before and after propensity score matching. Conclusions Levosimendan did not increase short- or long-term mortality rates in critical patients with acute heart failure and reduced ejection fraction compared to dobutamine, regardless of their renal function. An eGFR less than 30 mL/min/1.73 m2 was not necessarily considered a contraindication for levosimendan in these patients.

Abnormal renal function as a cause of false-positive biochemical screening for Down's syndrome

The Lancet ◽  
1997 ◽  
Vol 350 (9087) ◽  
pp. 1295 ◽  
Author(s):  
V Cararach ◽  
E Casals ◽  
S Martínez ◽  
F Carmona ◽  
C Aibar ◽  
...  
Keyword(s):  
Renal Function ◽  
False Positive ◽  
Down's Syndrome ◽  
Down’S Syndrome ◽  
Biochemical Screening ◽  
Abnormal Renal Function

scholarly journals Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?

PLoS ONE ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e0149562
Author(s):  
Jasmine R. Marcelin ◽  
Melody L. Berg ◽  
Eugene M. Tan ◽  
Hatem Amer ◽  
Nathan W. Cummins ◽  
...  
Keyword(s):  
Renal Function ◽  
Tenofovir Disoproxil Fumarate ◽  
Urine Protein ◽  
Abnormal Renal Function

Handling of Drugs in Children with Abnormal Renal Function

2015 ◽  
pp. 2267-2293
Author(s):  
Guido Filler ◽  
Amrit Kirpalani ◽  
Bradley L. Urquhart
Keyword(s):  
Renal Function ◽  
Abnormal Renal Function

Handling of Drugs in Children with Abnormal Renal Function-

2015 ◽  
pp. 1-28
Author(s):  
Guido Filler ◽  
Amrit Kirpalani ◽  
Bradley L. Urquhart
Keyword(s):  
Renal Function ◽  
Abnormal Renal Function

Betaxolol kinetics in hypertensive children with normal and abnormal renal function

1984 ◽  
Vol 35 (2) ◽  
pp. 141-147 ◽  
Author(s):  
Raffaele Palminteri ◽  
Baroukh M Assael ◽  
Gabrio Bianchetti ◽  
Roberto Gomeni ◽  
Aldo Claris-Appiani ◽  
...  
Keyword(s):  
Renal Function ◽  
Abnormal Renal Function

scholarly journals Reduced nephron endowment in the neonates of Indigenous Australian peoples

2013 ◽  
Vol 5 (1) ◽  
pp. 31-35 ◽  
Author(s):  
Y. Kandasamy ◽  
R. Smith ◽  
I. M. R. Wright ◽  
E. R. Lumbers
Keyword(s):  
Blood Pressure ◽  
Renal Function ◽  
Filtration Rate ◽  
Blood Pressure Measurement ◽  
Tertiary Care ◽  
Secondary Outcome ◽  
Preterm Neonates ◽  
Kidney Volume ◽  
Nephron Number ◽  
Renal Sonography

Rates of chronic kidney disease (CKD) among Indigenous groups in Australia exceed non-Indigenous rates eight-fold. Using kidney volume as a surrogate for nephron number, we carried out a study to determine if Indigenous neonates have a smaller kidney volume (and thus a reduced nephron number) from birth compared with non-Indigenous neonates. We recruited term and preterm neonates (<32 weeks) at a tertiary care neonatal unit over a 12 months period. Preterm neonates were assessed (renal sonography and renal function measurement) at 32 weeks corrected age (CA) and again at 38 weeks CA when blood pressure was also measured. All term neonates were assessed in the first post-natal week, including renal sonography, renal function and blood pressure measurement. The primary outcome measured was total kidney volume (TKV) and estimated glomerular filtration rate (eGFR) was a secondary outcome. Data was available for 44 preterm (11 Indigenous) and 39 term (13 Indigenous) neonates. TKV of Indigenous neonates was significantly lower at 32 weeks [12.0 (2.0)v.15.4 (5.1) ml;P=0.03] and 38 weeks CA [18.6 (4.0)v.22.6 (5.9) ml;P=0.04] respectively. Term Indigenous neonates also had smaller kidney volumes compared with non-Indigenous neonates. Despite a smaller kidney volume (and reduced nephron number), Indigenous neonates did not have a significantly lower eGFR. Indigenous neonates achieve similar eGFRs to Non-Indigenous neonates, presumably through a higher single nephron filtration rate. This places Indigenous neonates at a greater risk of long-term kidney damage later in life.

Renal Protection in Patients Undergoing Cardiopulmonary Bypass with Preoperative Abnormal Renal Function

1998 ◽  
Vol 42 (6) ◽  
pp. 316???317
Author(s):  
GUILLERMO LEMA ◽  
JORGE URZUA ◽  
ROBERTO JALIL ◽  
ROBERTO CANESSA ◽  
SERGIO MORAN ◽  
...  
Keyword(s):  
Renal Function ◽  
Cardiopulmonary Bypass ◽  
Renal Protection ◽  
Abnormal Renal Function
Sign in / Sign up

Export Citation Format

Share Document